摘要
Abstract
Objective To explore joint glargine insulin aspart treatment of type 2 diabetes treatment benefit. Methods Select from January 2012 to June 2014 68 hospitalized patients with type 2 diabetes in hospitalized patients were randomly divided into joint glargine insulin aspart group(experimental group)and insulin pump (control group) were 34 cases,two group were to receive formal diabetic diet,exercise instruction and other educational,lifestyle and treatment time rule.All patients in the experimental group were to be insulin aspart(early,before the dinner,immediate subcutaneous injection,aspart)+glargine(before sleep,subcutaneous,Lantus)treatment;all patients in the control group were to be continuous subcutaneous insulin aspart insulin pump,patients were observed dally fasting blood glucose,blood glucose 2 hours after a meal 3,10 pm glucose,fasting C-peptide,fasting blood amylase,lipase fasting,dally blood sugar fluctuations,insulin dosage dally,the number of cases of low blood sugar,body mass index,the standard treatment time and cost of treatment. Results Each group before and after treatment of blood glucose control,fasting C peptide,amylase,lipase on an empty stomach on an empty stomach these indicators were statistically significant (P < 0.05),body mass index had no statistical difference(P > 0.05);Two groups of day of insulin,blood sugar volatility no statistical difference(P > 0.05);The experimental group was lower than those of control group in treatment costs,low blood sugar more than the number of cases(P < 0.05),but long time needed for standard(P<0.05). Conclusion Joint insulin aspart insulin glargine high incidence of hypoglycemia,a long time standard,but low cost,suitable for primary hospital patients and difficult economy,it is worth promoting.关键词
门冬胰岛素/甘精胰岛素/2型糖尿病/疗效/胰腺功能Key words
Insulin aspart/Glargine/Type 2 diabetes/Efficacy/Pancreatic function分类
医药卫生
